Skip to main content
. Author manuscript; available in PMC: 2014 Jul 31.
Published in final edited form as: JAMA Dermatol. 2014 Apr;150(4):390–400. doi: 10.1001/jamadermatol.2013.6896

Table 1.

Primary Analyses by Sex and Participant Category

Exposure by Group Overall
Female Participants
Male Participants
Summary Prevalence (95% CI) Records, No. SummaryPrevalence (95%CI) No. of Records Summary Prevalence (95% CI) No. of Records
Adults
    Ever exposure 35.7 (27.5-44.0) 22 39.8 (30.0-49.7) 9 20.4 (12.4-28.3)a 7
    Past-year exposure 14.0 (11.5-16.5) 21 19.0 (14.7-23.4) 15 9.0 (6.6-11.5) 13
University students
    Ever exposure 55.0 (33.0-77.1) 11 69.3 (45.4-93.2) 5 40.0 (14.1-66.0) 3
    Past-year exposure 43.1 (21.7-64.5) 7 64.9 (41.2-88.5) 4 26.8 (15.6-37.9) 4
Adolescents
    Ever exposure 19.3 (14.7-24.0) 23 31.5 (22.3-40.8) 16 14.1 (10.5-17.7)a 17
    Past-year exposure 18.3 (12.6-24.0) 23 21.3 (8.5-34.1) 14 7.5 (4.1-11.0)a 14
a

Including 1 or 2 individual prevalence estimates in which exact methods were used to calculate 95% CIs.